The Hyderabad International Airport Limited and the GMR Hyderabad Air Cargo signed a memorandum of understanding (MoU) with Dubai Airport.
The MoU was signed by Pradeep Panicker, the Chief Executive Officer (CEO) of GMR Hyderabad International Airport (HIA,) Saurabh Kumar, CEO of GMR Hyderabad Air Cargo and Eugene Barry, Employee Value Proposition (EVP) Commercial, Dubai Airports Corporation in a virtual ceremony organised last week.
Though the virtual MoU signing event was held last week, the news was made official on the 4th of January.
The MoU was a step to agree on an initiative to build an exclusive Vaccine Air Freight Corridor Product named HYDXB-VAXCOR (Hyderabad to Dubai global Vaccine Corridor.)
On the 4th of January, the sources close to development said, the MoU was signed in the backdrop of the City becoming a hub for the Novel Coronavirus or COVID-19 vaccine.
This agreement will lead to the rollout of customised and simplified processes and infrastructural support to streamline the journey of COVID-19 vaccine export/import from the manufacturing unit to the airport and hub logistics to delivery to end customers.
Mr. Panicker said, “We are also significantly upgrading our handling capacities for Covid-19 Vaccine shipments requiring Cold to ultra-cold temperature ranges and becoming India’s largest Air Cargo centre both for Export/Imports and Domestic distribution of the Vaccine.”
Paul Griffiths, the CEO of Dubai Airports, said a major surge in demand for the efficient, safe and reliable global distribution of high volumes of COVID-19 vaccines is expected in the coming months. Hence, the MoU signed would be a better initiative taken by Hyderabad and Dubai.
Paul Griffiths said, “As the world’s preeminent hub of choice, we wanted to be ready to respond to and accommodate that demand. Our partnership with GMR-Hyderabad is timed perfectly just as the global race to develop the vaccines enters the final stage.
This corridor is the result of our proactive strategy to be ready with innovative, collaborative and agile shipping solutions for the industry.”
Meanwhile, Hyderabad based Bharat Biotech International Private Limited on the 3rd of January got approval for it’s COVAXIN.
Besides Hyderabad bases Bharat Biotech, Serum Institute of India (SII) also got EAU approval.
Stay tuned for further updates.